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Smooth muscle tumors of undermined malignant potential (STUMP) are atypical smooth muscle tumors. The majority of these
tumors are of uterine origin. We report the ﬁrst known periurethral STUMP. Complete surgical resection is recommended for all
cases of STUMP. They can recur in the form of STUMP or leiomyosarcoma.
1.Introduction
Smoothmuscletumorsofundeterminedmalignantpotential
(STUMP) are rare smooth muscle tumors that are not
deﬁnitivelybenignormalignantonhistologicevaluation[1].
The majority of STUMPs are of uterine origin. In this paper,
wepresenttheﬁrstknowncaseofaperiurethralSTUMPthat
was treated by surgical excision.
2.CaseReport
A 37-year-old nulligravid female presented to our clinic for
anannualgynecologicexamination.Therewerenoabnormal
ﬁndings noted on pelvic exam and a screening Pap smear
was performed. Four weeks later, the patient returned for a
colposcopicexaminationforﬁndingsoflow-gradesquamous
intraepithelial lesion on her Pap smear. She was without
complaint at this follow-up visit. However, her cervix was
obstructed from view by a new anterior vaginal wall mass.
The patient was sent for voiding cystourethrogram (VCUG),
which did not demonstrate a urethral diverticulum. Subse-
quently, the patient was sent for magnetic resonance imaging
(MRI). The MRI characterized a 4.6 × 4.2 × 4.0c e n t i m e t e r
mass located within the anterior vaginal wall with mild
homogeneous enhancement (Figure 1). After consultation
with a urogynecology specialist, the patient was taken to the
operating theater for excision of the mass via the vaginal
approach. A transverse incision was made along the anterior
vaginal wall epithelium overlying the periurethral mass. Two
solid individual masses were then carefully dissected away
from the urethra. The periurethral tissues were closed in
layers using a pants-over-suit technique.
A gross inspection by the surgeons revealed two soft,
tan, smooth masses with no evidence of necrosis upon
cross-section. They were felt to be periurethral leiomyomas
and were sent to pathology for permanent section. The
dimensions of the masses were 4.3 × 3.5 × 3.5c e n t i m e t e r s
and 4.0×3.7×2.5 centimeters. Final histopathology revealed
smooth muscle tumors with diﬀu s em o d e r a t ea t y p i a ,a b s e n t
necrosis, and less than 2 mitotic ﬁgures (MFs) per 10 high
powered ﬁelds (HPFs) (Figure 2). The ﬁnal diagnosis was
STUMP. A second, independent pathologist was consulted
and agreed.
3. Discussion
Three recognized features of malignant smooth muscle
tumors are moderate-to-severe cytologic atypia, a mitotic
count of ≥1 0M Fp e r1 0 H P F ,a n dt u m o rc e l ln e c r o s i s .I f
a tumor is clinically malignant with 2 of the 3 features, it2 Case Reports in Obstetrics and Gynecology
Figure 1: T2-weighted MRI of the pelvic characterized a 4.6×4.2×
4.0 centimeter mass located within the anterior vaginal wall with
mild homogeneous enhancement.
Figure 2: Hematoxylin and eosin stain of periurethral STUMP
tissue showing diﬀuse moderate atypia.
is diagnosed as a leiomyosarcoma [2]. In contrast, benign
leiomyomas are deﬁned as smooth muscle tumors with
no atypia ≤4MF per 10HPF and no tumor cell necrosis.
Smooth muscle tumors that do not ﬁt into these categories
are diagnosed as STUMP. Most STUMPs are of uterine
origin.Inourliteraturesearch,therehadonlybeenoneother
case of extrauterine STUMP, describing a vulvar STUMP
with local recurrence in a 10-year-old patient [3]. It is
unclear whether extrauterine STUMPs have diﬀerent clinical
courses when compared to those of uterine origin. The
diagnosis of periurethral STUMP in our patient represents
an extremely rare occurrence of extrauterine STUMP. This
is the ﬁrst report known to these authors of STUMP
involving the anterior vaginal wall. It is diﬃcult to predict
the clinical outcome for this patient, as the clinical courses
of uterine STUMP are widely variable. In a retrospective
review of 41 cases of uterine STUMP, there was an overall
7 percent recurrence rate in the form of both STUMP and
leiomyosarcoma [4].
There is no consensus for the clinical management of
patients with STUMP. Complete surgical resection is the
initial treatment. Currently there is no role for adjuvant
chemotherapy or radiation therapy following initial surgical
treatment.Duetothepossibilityofrecurrenceandmalignant
transformation of STUMP, these patients require followup
more frequently than annual visits. In our case, we plan to
follow our patient every 3 months with pelvic exams for
two years, saving MRI for any suspected recurrence. Future
studies are needed to propose recommendations for the
clinical management of extrauterine STUMP.
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